This is a Proprietary Laboratory Analyses (PLA) code, meaning that the code applies to only one unique lab test made by a specific manufacturer or performed by a specific lab. Report 0242U for Guardant360® CDx from Guardant Health, Inc. The test uses next generation sequencing (NGS) to evaluate cell–free DNA from a blood specimen for 55–74 genes associated with solid–organ tumors.
For clinical responsibility, terminology, tips and additional info
start codify free trial.